BEAM (BEAM) Stock Price & Analysis
BEAM (BEAM) rose 0.68% to USD 29.66 as of September 8, 2026 at 04:21 UTC, according to Nexqual real-time market data.
BEAM last closed at USD 29.66; the session ranged USD 28.91–29.97 on volume of 1,183,164 shares. Market capitalization is —, with a 52-week range of USD 19.36–38.26 (NMS). Source: Nexqual, September 8, 2026 at 04:21 UTC.
Key Statistics (as of September 8, 2026 at 04:21 UTC)
| Price | USD 29.66 |
|---|---|
| Change | ▲ 0.68% (up) |
| Previous Close | USD 29.66 |
| Open | USD 29.66 |
| Day Range | USD 28.91 – 29.97 |
| 52-Week Range | USD 19.36 – 38.26 |
| Volume | 1,183,164 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BEAM)
Nexqual's technical model rates BEAM "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:21 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.92 (neutral) |
| vs SMA50 | Above (USD 29.35) |
| MACD | 0.37 (positive) |
From BEAM's Latest SEC 10-K Filing (filed 2026-02-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | USD 12.74 | ▼ 0.16% |
| EDIT | Editas Medicine, Inc. | USD 3.23 | ▲ 4.87% |
| TWST | Twist Bioscience Corporation | USD 124.72 | ▼ 4.79% |
| CRSP | CRISPR Therapeutics AG | USD 55.79 | ▼ 1.99% |
| FATE | Fate Therapeutics, Inc. | USD 2.48 | ▲ 1.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:21 UTC. This page is informational and not investment advice.